|
Mediwatch PLC - Comparative Business Analysis Snapshot
Business Description
Mediwatch PLC. The Group's principal activity is developing primary care products used in the diagnosis of urological disorders and early prostate cancer detection. Its operation focuses on such areas urology, bladder assessment, erectile dysfunction, urogynaecology, incontinence and near-patient testing. The Group operates in three divisions: ultrasound, urodynamics and biochemistry. Its products include Portascan+, Multiscan and Multiscan PVR in ultrasound; Urodyn 1000, Portaflow, Duet Logic G2, Duet Encompass and Duet Logic Sensic G3, Disposables and Erectease in urodynamics and PSAWatch, Bioscan and BTA in biochemistry. The Group operates predominantly in the United Kingdom.
Competitor Analysis
This analysis compares Mediwatch PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
